FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985957029> ?p ?o ?g. }

• W1985957029 endingPage "4751" @default.
• W1985957029 startingPage "4735" @default.
• W1985957029 abstract "The phosphoinositide 3-kinase (PI3K) family catalyzes the ATP-dependent phosphorylation of the 3′-hydroxyl group of phosphatidylinositols and plays an important role in cell growth and survival. There is abundant evidence demonstrating that PI3K signaling is dysregulated in many human cancers, suggesting that therapeutics targeting the PI3K pathway may have utility for the treatment of cancer. Our efforts to identify potent, efficacious, and orally available PI3K/mammalian target of rapamycin (mTOR) dual inhibitors resulted in the discovery of a series of substituted quinolines and quinoxalines derivatives. In this report, we describe the structure–activity relationships, selectivity, and pharmacokinetic data of this series and illustrate the in vivo pharmacodynamic and efficacy data for a representative compound." @default.
• W1985957029 created "2016-06-24" @default.
• W1985957029 creator A5000886111 @default.
• W1985957029 creator A5003543491 @default.
• W1985957029 creator A5010906992 @default.
• W1985957029 creator A5013507207 @default.
• W1985957029 creator A5017725600 @default.
• W1985957029 creator A5019502209 @default.
• W1985957029 creator A5022335574 @default.
• W1985957029 creator A5023931623 @default.
• W1985957029 creator A5027637263 @default.
• W1985957029 creator A5032337429 @default.
• W1985957029 creator A5033334328 @default.
• W1985957029 creator A5036762272 @default.
• W1985957029 creator A5037958863 @default.
• W1985957029 creator A5041017678 @default.
• W1985957029 creator A5049605524 @default.
• W1985957029 creator A5049963981 @default.
• W1985957029 creator A5050487837 @default.
• W1985957029 creator A5053060128 @default.
• W1985957029 creator A5066158150 @default.
• W1985957029 creator A5082357729 @default.
• W1985957029 creator A5086235609 @default.
• W1985957029 creator A5089908847 @default.
• W1985957029 date "2011-06-20" @default.
• W1985957029 modified "2023-10-16" @default.
• W1985957029 title "Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure–Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives" @default.
• W1985957029 cites W1981711832 @default.
• W1985957029 cites W2009886463 @default.
• W1985957029 cites W2018153260 @default.
• W1985957029 cites W2040381937 @default.
• W1985957029 cites W2070732456 @default.
• W1985957029 cites W2087012714 @default.
• W1985957029 cites W2108558461 @default.
• W1985957029 cites W2124593509 @default.
• W1985957029 cites W2143856302 @default.
• W1985957029 cites W2161437969 @default.
• W1985957029 cites W2166199762 @default.
• W1985957029 cites W2169303908 @default.
• W1985957029 cites W3005234769 @default.
• W1985957029 doi "https://doi.org/10.1021/jm200386s" @default.
• W1985957029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21612232" @default.
• W1985957029 hasPublicationYear "2011" @default.
• W1985957029 type Work @default.
• W1985957029 sameAs 1985957029 @default.
• W1985957029 citedByCount "54" @default.
• W1985957029 countsByYear W19859570292012 @default.
• W1985957029 countsByYear W19859570292013 @default.
• W1985957029 countsByYear W19859570292014 @default.
• W1985957029 countsByYear W19859570292015 @default.
• W1985957029 countsByYear W19859570292016 @default.
• W1985957029 countsByYear W19859570292017 @default.
• W1985957029 countsByYear W19859570292018 @default.
• W1985957029 countsByYear W19859570292019 @default.
• W1985957029 countsByYear W19859570292020 @default.
• W1985957029 countsByYear W19859570292021 @default.
• W1985957029 countsByYear W19859570292022 @default.
• W1985957029 countsByYear W19859570292023 @default.
• W1985957029 crossrefType "journal-article" @default.
• W1985957029 hasAuthorship W1985957029A5000886111 @default.
• W1985957029 hasAuthorship W1985957029A5003543491 @default.
• W1985957029 hasAuthorship W1985957029A5010906992 @default.
• W1985957029 hasAuthorship W1985957029A5013507207 @default.
• W1985957029 hasAuthorship W1985957029A5017725600 @default.
• W1985957029 hasAuthorship W1985957029A5019502209 @default.
• W1985957029 hasAuthorship W1985957029A5022335574 @default.
• W1985957029 hasAuthorship W1985957029A5023931623 @default.
• W1985957029 hasAuthorship W1985957029A5027637263 @default.
• W1985957029 hasAuthorship W1985957029A5032337429 @default.
• W1985957029 hasAuthorship W1985957029A5033334328 @default.
• W1985957029 hasAuthorship W1985957029A5036762272 @default.
• W1985957029 hasAuthorship W1985957029A5037958863 @default.
• W1985957029 hasAuthorship W1985957029A5041017678 @default.
• W1985957029 hasAuthorship W1985957029A5049605524 @default.
• W1985957029 hasAuthorship W1985957029A5049963981 @default.
• W1985957029 hasAuthorship W1985957029A5050487837 @default.
• W1985957029 hasAuthorship W1985957029A5053060128 @default.
• W1985957029 hasAuthorship W1985957029A5066158150 @default.
• W1985957029 hasAuthorship W1985957029A5082357729 @default.
• W1985957029 hasAuthorship W1985957029A5086235609 @default.
• W1985957029 hasAuthorship W1985957029A5089908847 @default.
• W1985957029 hasConcept C178790620 @default.
• W1985957029 hasConcept C184235292 @default.
• W1985957029 hasConcept C185592680 @default.
• W1985957029 hasConcept C193042331 @default.
• W1985957029 hasConcept C202751555 @default.
• W1985957029 hasConcept C207001950 @default.
• W1985957029 hasConcept C2776309666 @default.
• W1985957029 hasConcept C2780362310 @default.
• W1985957029 hasConcept C54355233 @default.
• W1985957029 hasConcept C55493867 @default.
• W1985957029 hasConcept C62478195 @default.
• W1985957029 hasConcept C74187038 @default.
• W1985957029 hasConcept C86554907 @default.
• W1985957029 hasConcept C86803240 @default.
• W1985957029 hasConcept C98274493 @default.
• W1985957029 hasConceptScore W1985957029C178790620 @default.
• W1985957029 hasConceptScore W1985957029C184235292 @default.

• next